Andre, while I agree with your 'sentient' analogy I also believe...

Andre, while I agree with your 'sentient' analogy I also believe that until we see further patient recruitment
evidence and continued successful trial results (which I fully expect we will) we probably wont see the SP
reflecting our true potential.

In the explicable absence of that narrative, I think it's fair to say that shareholder sentiment will stay idle.
As long as our project developments and research trajectories stay on course (again, I fully expect that they
will) well, it is not presumptive at all to believe that we will achieve and even exceed previous SP levels; I
don't believe there's any compelling evidence to believe/support anything else.